Nicholas Voss - Concepedia

Author

Nicholas Voss

Also Known As

N J Voss, N Voss, N. J. Voss, N. Voss, N.J. Voss, N.J.S. Voss, Nicholas J. S. Voss, Nicholas J. Voss, Nicholas J.S. Voss, Nicholas Voss

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

BC Cancer Agency University of British Columbia Vancouver Hospital and Health Sciences Centre Vancouver General Hospital

About

Nicholas Voss is an author at BC Cancer Agency specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	570
2	Immunology	5	5	254
3	Health Sciences	4	4	167
4	Blood Transplantation	3	3	187
5	Cellular Therapies	2	2	165

Nicholas Voss

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience Kerry J. Savage, N. Al-Rajhi, Nicholas Voss, Annals of Oncology Lymphoid NeoplasiaBritish Columbia ExperiencePathologyFavorable OutcomeSingle Institution	2005	249
Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988 Andreas Lohri, Michael Barnett, RN Fairey, Blood	1991	129
High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver Julye C. Lavoie, Joseph M. Connors, Gordon L. Phillips, Blood	2005	121
Limited-stage mantle-cell lymphoma Heather A. Leitch, Randy D. Gascoyne, Mukesh Chhanabhai, Annals of Oncology Lymphoid NeoplasiaMedicineHematologyHistopathologyPathology	2003	107
Testicular lymphoma: improved outcome with early brief chemotherapy. Joseph M. Connors, Paul Klimo, Nicholas Voss, Journal of Clinical Oncology Testicular LymphomaLymphoid NeoplasiaRadiation TherapyElderly PatientsMedicine	1988	88
Allogeneic haematopoietic stem‐cell transplantation for relapsed and refractory aggressive histology non‐Hodgkin lymphoma* Richard Doocey, Cynthia L. Toze, Joseph M. Connors, British Journal of Haematology Cell TherapyLymphoma RelapseTransplantation MedicineImmunologyPathology	2005	86
Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease Cynthia L. Toze, Alia Galal, Michael J. Barnett, Bone Marrow Transplantation Cell TherapyTransplantationChronic Lymphocytic LeukemiaImmunologyHematology	2005	79
High-Dose Therapy and Autologous Hematopoietic Stem-Cell Transplantation Does Not Increase the Risk of Second Neoplasms for Patients With Hodgkin's Lymphoma: A Comparison of Conventional Therapy Alone Versus Conventional Therapy Followed by Autologous Hematopoietic Stem-Cell Transplantation Donna L. Forrest, Donna E. Hogge, Thomas J. Nevill, Journal of Clinical Oncology	2005	58
Primary paranasal sinus lymphoma: natural history and improved outcome with central nervous system chemoprophylaxis Janessa Laskin, Kerry J. Savage, Nicholas Voss, Leukemia & lymphoma/Leukemia and lymphoma Extranodal LymphomaLymphoid NeoplasiaParanasal SinusParanasal Sinus LymphomaNatural History	2005	56
Long‐term disease‐free survival of patients with advanced follicular lymphoma after allogeneic bone marrow transplantation Cynthia L. Toze, Michael J. Barnett, Joseph M. Connors, British Journal of Haematology Advanced Follicular LymphomaTransplantation MedicineImmunologyPathologyLong‐term Disease‐free Survival	2004	53

Page 1